Cite
HARVARD Citation
Lee, J. et al. (2022). An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab. Rheumatology advances in practice. 6 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, J. et al. (2022). An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab. Rheumatology advances in practice. 6 (2), p. . [Online].